EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

CRISPRi-mediated tunable control of gene expression level with engineered single-guide RNA in Escherichia coli

Gibyuck Byun, Jina Yang, Sang Woo Seo iD

Nucleic Acids Research · 22.05.2023 · 51 (9) · 4650-4659

DOI: 10.1093/nar/gkad234 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 31.03.2023. Verfasst von Gibyuck Byun und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical and Biological Engineering, 1 Gwanak-ro, Gwanak-Gu, Seoul 08826, Korea. Hauptthemen laut MEDLINE: Escherichia coli, Gene Expression Regulation, Bacterial, RNA, Guide, CRISPR-Cas Systems, Metabolic Networks and Pathways. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Bio & Medical Technology Development Program, National Research Foundation, Ministry of Science and ICT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Precise control of gene expression is essential for flux redistribution in metabolic pathways. Although the CRISPR interference (CRISPRi) system can effectively repress gene expression at the transcriptional level, it has still been difficult to precisely control the level without loss of specificity or an increase in cell toxicity. In this study, we developed a tunable CRISPRi system that performs transcriptional regulation at various levels. We constructed a single-guide RNA (sgRNA) library targeting repeat, tetraloop, and anti-repeat regions to modulate the binding affinity against dCas9. Each screened sgRNA could regulate the gene expression at a certain level between fully-repressing and non-repressing states (>45-fold). These sgRNAs also enabled modular regulation with various target DNA sequences. We applied this system to redistribute the metabolic flux to produce violacein derivatives in a predictable ratio and optimize lycopene production. This system would help accelerate the flux optimization processes in metabolic engineering and synthetic biology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Escherichia coliGene Expression Regulation, BacterialRNA, Guide, CRISPR-Cas SystemsMetabolic Networks and PathwaysClustered Regularly Interspaced Short Palindromic RepeatsCRISPR-Cas Systems

Substanzen

RNA, Guide, CRISPR-Cas Systems

Autor:innen und Institutionen

  • School of Chemical and Biological Engineering, 1 Gwanak-ro, Gwanak-Gu, Seoul 08826, Korea.
  • Department of Chemical Engineering, Jeju National University, 102, Jejudaehak-ro, Jeju-si, Jeju-do 63243, Korea.
  • Interdisciplinary Program in Bioengineering, 1 Gwanak-ro, Gwanak-Gu, Seoul 08826, Korea.
  • Institute of Chemical Process, 1 Gwanak-ro, Gwanak-Gu, Seoul 08826, Korea.
  • Bio-MAX Institute, 1 Gwanak-ro, Gwanak-Gu, Seoul 08826, Korea.
  • Institute of Engineering Research, Seoul National University, 1 Gwanak-ro, Gwanak-Gu, Seoul 08826, Korea.

ORCID-Profile: Sang Woo Seo

Förderung

  • Bio & Medical Technology Development Program
  • National Research Foundation
  • Ministry of Science and ICT
  • Korea Institute of Marine Science & Technology Promotion
  • Ministry of Oceans and Fisheries

Zitieren

APA

Byun, G., Yang, J., & Seo, S. W. (2023). CRISPRi-mediated tunable control of gene expression level with engineered single-guide RNA in Escherichia coli. Nucleic Acids Research, 51(9), 4650-4659. https://doi.org/10.1093/nar/gkad234

Vancouver

Byun G, Yang J, Seo SW. CRISPRi-mediated tunable control of gene expression level with engineered single-guide RNA in Escherichia coli. Nucleic Acids Research. 2023;51(9):4650-4659. doi:10.1093/nar/gkad234

BibTeX
@article{Byun2023,
  author = {Byun, Gibyuck and Yang, Jina and Seo, Sang Woo},
  title = {CRISPRi-mediated tunable control of gene expression level with engineered single-guide RNA in Escherichia coli},
  journal = {Nucleic Acids Research},
  year = {2023},
  volume = {51},
  number = {9},
  pages = {4650--4659},
  doi = {10.1093/nar/gkad234}
}
Kostenlos starten →